tetano
Editor, Senior Moderator
Best Pract Res Clin Endocrinol Metab
. 2023 Mar 5;101761.
doi: 10.1016/j.beem.2023.101761. Online ahead of print.
SARS-CoV-2 infection and its effects on the endocrine system
Charlotte Steenblock[SUP] 1 [/SUP], Nicole Toepfner[SUP] 2 [/SUP], Felix Beuschlein[SUP] 3 [/SUP], Nikolaos Perakakis[SUP] 4 [/SUP], Ranjit Mohan Anjana[SUP] 5 [/SUP], Viswanathan Mohan[SUP] 5 [/SUP], Nitish R Mahapatra[SUP] 6 [/SUP], Stefan R Bornstein[SUP] 7 [/SUP]
Affiliations
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing corona virus disease 2019 (COVID-19) can infect multiple tissues, including endocrine organs, such as the pancreas, adrenal, thyroid, and adipose tissue. The main receptor for SARS-CoV-2, ACE2, is ubiquitously expressed in the cells of the endocrine organs and accordingly, the virus has been detected in various amounts in all endocrine tissues in post-mortem samples from COVID-19 patients. The infection with SARS-CoV-2 may directly lead to organ damage or dysfunction, such as hyperglycaemia or in rare cases, new-onset diabetes. Furthermore, an infection with SARS-CoV-2 may have indirect effects affecting the endocrine system. The exact mechanisms are not yet completely understood and have to be further investigated. Conversely, endocrine diseases may affect the severity of COVID-19 and emphasis has to be laid on reducing the prevalence, or enhance the treatment, of these often non-communicable diseases in the future.
Keywords: ACE2; COVID-19; SARS-CoV-2; autoimmune; endocrine; metabolic.
. 2023 Mar 5;101761.
doi: 10.1016/j.beem.2023.101761. Online ahead of print.
SARS-CoV-2 infection and its effects on the endocrine system
Charlotte Steenblock[SUP] 1 [/SUP], Nicole Toepfner[SUP] 2 [/SUP], Felix Beuschlein[SUP] 3 [/SUP], Nikolaos Perakakis[SUP] 4 [/SUP], Ranjit Mohan Anjana[SUP] 5 [/SUP], Viswanathan Mohan[SUP] 5 [/SUP], Nitish R Mahapatra[SUP] 6 [/SUP], Stefan R Bornstein[SUP] 7 [/SUP]
Affiliations
- PMID: 36907787
- DOI: 10.1016/j.beem.2023.101761
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing corona virus disease 2019 (COVID-19) can infect multiple tissues, including endocrine organs, such as the pancreas, adrenal, thyroid, and adipose tissue. The main receptor for SARS-CoV-2, ACE2, is ubiquitously expressed in the cells of the endocrine organs and accordingly, the virus has been detected in various amounts in all endocrine tissues in post-mortem samples from COVID-19 patients. The infection with SARS-CoV-2 may directly lead to organ damage or dysfunction, such as hyperglycaemia or in rare cases, new-onset diabetes. Furthermore, an infection with SARS-CoV-2 may have indirect effects affecting the endocrine system. The exact mechanisms are not yet completely understood and have to be further investigated. Conversely, endocrine diseases may affect the severity of COVID-19 and emphasis has to be laid on reducing the prevalence, or enhance the treatment, of these often non-communicable diseases in the future.
Keywords: ACE2; COVID-19; SARS-CoV-2; autoimmune; endocrine; metabolic.